Please login to the form below

Not currently logged in
Email:
Password:

James Mond joins Absynth Biologics as chief medical officer

Will lead plans to develop vaccines and antibodies to tackle bacterial infections including MRSA

Absynth Biologics, the UK-based developer of vaccines and antibodies for bacterial infections, has appointed Dr James Mond as chief medical officer.

Dr Mond's previous experience in the vaccination industry includes working as a consultant to Virion Systems, where he oversaw development of a vaccine technology that was later licensed to GlaxoSmithKline (GSK).

Most recently, Dr Mond was executive vice president and chief scientific officer of Biosynexus, a biopharma company whose main focus was on developing a monoclonal antibody to prevent staphylococcal infections in children with a low birth weight.

At Absynth, Dr Mond will direct strategy and manage activities related to the company's vaccine and antibody programme to target staphylococcus aureus (S. Aureus), a bacteria whose strains include the antibiotic resistant infection MRSA.

“I am delighted to have someone of James' experience join Absynth at a time when we are reaching important milestones in our S. Aureus programmes and expect to see significant developments in building our R&D pipeline during the next few years,” said Fiona Marston, chief executive of Absynth.

29th May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics